Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aortic Aneurysm, Thoracic | 2 | 2020 | 678 | 0.880 |
Why?
|
Peripheral Arterial Disease | 4 | 2022 | 1169 | 0.850 |
Why?
|
Endovascular Procedures | 7 | 2022 | 1947 | 0.810 |
Why?
|
Aortic Aneurysm, Abdominal | 4 | 2022 | 1178 | 0.780 |
Why?
|
Blood Vessel Prosthesis Implantation | 6 | 2022 | 1381 | 0.770 |
Why?
|
Arthritis, Experimental | 2 | 2014 | 291 | 0.710 |
Why?
|
Spinal Cord Ischemia | 1 | 2020 | 91 | 0.670 |
Why?
|
Liver Circulation | 1 | 2018 | 162 | 0.620 |
Why?
|
Splanchnic Circulation | 1 | 2018 | 110 | 0.620 |
Why?
|
Mesenteric Artery, Superior | 1 | 2018 | 101 | 0.610 |
Why?
|
Hepatic Artery | 1 | 2018 | 242 | 0.580 |
Why?
|
Blood Grouping and Crossmatching | 1 | 2016 | 106 | 0.550 |
Why?
|
Aneurysm | 1 | 2018 | 339 | 0.490 |
Why?
|
Femoral Artery | 2 | 2021 | 841 | 0.490 |
Why?
|
Radiography, Interventional | 2 | 2018 | 1093 | 0.460 |
Why?
|
Denervation | 1 | 2014 | 276 | 0.450 |
Why?
|
Postoperative Hemorrhage | 1 | 2016 | 410 | 0.430 |
Why?
|
Unnecessary Procedures | 1 | 2016 | 428 | 0.430 |
Why?
|
Hindlimb | 1 | 2014 | 507 | 0.430 |
Why?
|
Blood Loss, Surgical | 1 | 2016 | 658 | 0.420 |
Why?
|
Endarterectomy, Carotid | 1 | 2016 | 543 | 0.390 |
Why?
|
Carotid Stenosis | 3 | 2023 | 851 | 0.390 |
Why?
|
Occupational Health | 1 | 2017 | 808 | 0.390 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2022 | 3066 | 0.380 |
Why?
|
Microvessels | 1 | 2014 | 544 | 0.360 |
Why?
|
Carotid Artery Diseases | 1 | 2016 | 879 | 0.360 |
Why?
|
Blood Transfusion | 1 | 2016 | 1296 | 0.350 |
Why?
|
Bacteriocins | 1 | 2009 | 90 | 0.340 |
Why?
|
Radiation Dosage | 1 | 2017 | 1920 | 0.340 |
Why?
|
Aortic Rupture | 2 | 2022 | 310 | 0.320 |
Why?
|
Androstenes | 1 | 2009 | 168 | 0.320 |
Why?
|
Ischemia | 3 | 2022 | 1908 | 0.300 |
Why?
|
Prodrugs | 1 | 2009 | 271 | 0.300 |
Why?
|
Bone Substitutes | 3 | 2006 | 228 | 0.300 |
Why?
|
Occupational Exposure | 1 | 2017 | 1791 | 0.300 |
Why?
|
Osteoblasts | 3 | 2006 | 1163 | 0.260 |
Why?
|
Lower Extremity | 2 | 2022 | 1145 | 0.220 |
Why?
|
Health Care Costs | 1 | 2016 | 3226 | 0.220 |
Why?
|
Music Therapy | 2 | 2013 | 100 | 0.200 |
Why?
|
Neutrophils | 2 | 2009 | 3698 | 0.180 |
Why?
|
Vascular Grafting | 1 | 2020 | 142 | 0.160 |
Why?
|
Wound Healing | 3 | 2020 | 2768 | 0.160 |
Why?
|
Bone and Bones | 2 | 2006 | 2575 | 0.150 |
Why?
|
Angioplasty | 1 | 2020 | 363 | 0.150 |
Why?
|
Autoimmune Diseases | 1 | 2009 | 2116 | 0.150 |
Why?
|
Saphenous Vein | 1 | 2020 | 527 | 0.150 |
Why?
|
Radiation Monitoring | 1 | 2017 | 98 | 0.150 |
Why?
|
Endothelium, Vascular | 1 | 2009 | 4454 | 0.150 |
Why?
|
Fluoroscopy | 2 | 2018 | 915 | 0.140 |
Why?
|
Inflammation | 2 | 2014 | 10534 | 0.140 |
Why?
|
Fibrinolytic Agents | 2 | 2022 | 2149 | 0.140 |
Why?
|
Treatment Outcome | 12 | 2022 | 62693 | 0.140 |
Why?
|
Thromboembolism | 1 | 2022 | 984 | 0.140 |
Why?
|
Immunosuppressive Agents | 1 | 2009 | 4143 | 0.140 |
Why?
|
Stents | 4 | 2023 | 3257 | 0.140 |
Why?
|
Aspirin | 3 | 2022 | 3268 | 0.130 |
Why?
|
Sarcoma | 3 | 2013 | 1888 | 0.130 |
Why?
|
Risk Factors | 9 | 2022 | 71974 | 0.120 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2018 | 431 | 0.120 |
Why?
|
Imaging, Three-Dimensional | 3 | 2018 | 4035 | 0.120 |
Why?
|
Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2013 | 8 | 0.120 |
Why?
|
Blood Vessel Prosthesis | 1 | 2018 | 932 | 0.120 |
Why?
|
Minoxidil | 1 | 2013 | 33 | 0.120 |
Why?
|
Angioplasty, Balloon | 1 | 2018 | 654 | 0.110 |
Why?
|
Metals | 1 | 2018 | 718 | 0.110 |
Why?
|
Serum | 1 | 2014 | 211 | 0.110 |
Why?
|
Gene Expression | 2 | 2005 | 7788 | 0.110 |
Why?
|
Paralysis | 1 | 2014 | 250 | 0.110 |
Why?
|
Risk Assessment | 6 | 2022 | 23294 | 0.110 |
Why?
|
Stroke | 3 | 2022 | 9898 | 0.100 |
Why?
|
Friends | 1 | 2013 | 153 | 0.100 |
Why?
|
Workload | 1 | 2017 | 843 | 0.100 |
Why?
|
Rats, Inbred WKY | 3 | 2006 | 158 | 0.100 |
Why?
|
Ankle | 1 | 2014 | 319 | 0.100 |
Why?
|
Retrospective Studies | 9 | 2022 | 76631 | 0.100 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 1185 | 0.100 |
Why?
|
Databases, Factual | 4 | 2020 | 7690 | 0.100 |
Why?
|
Cost Savings | 1 | 2016 | 925 | 0.100 |
Why?
|
Cell Hypoxia | 1 | 2013 | 676 | 0.090 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2012 | 320 | 0.090 |
Why?
|
Spinal Cord | 1 | 2018 | 1818 | 0.090 |
Why?
|
Matrix Metalloproteinases | 1 | 2012 | 391 | 0.090 |
Why?
|
Surgery, Computer-Assisted | 1 | 2018 | 1008 | 0.090 |
Why?
|
Vascular Diseases | 1 | 2018 | 1152 | 0.090 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2009 | 63 | 0.090 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 628 | 0.090 |
Why?
|
Cell Differentiation | 3 | 2005 | 11460 | 0.090 |
Why?
|
Equipment Design | 1 | 2017 | 3583 | 0.090 |
Why?
|
Aged | 8 | 2022 | 162698 | 0.080 |
Why?
|
Humans | 24 | 2023 | 739398 | 0.080 |
Why?
|
Time Factors | 8 | 2020 | 40050 | 0.080 |
Why?
|
Factor XIII | 1 | 2008 | 59 | 0.080 |
Why?
|
Embolization, Therapeutic | 1 | 2018 | 1376 | 0.080 |
Why?
|
Task Performance and Analysis | 1 | 2012 | 780 | 0.080 |
Why?
|
Anticoagulants | 2 | 2022 | 4582 | 0.080 |
Why?
|
Androstadienes | 1 | 2009 | 340 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 4743 | 0.080 |
Why?
|
Carotid Arteries | 2 | 2022 | 952 | 0.080 |
Why?
|
Spectroscopy, Near-Infrared | 2 | 2012 | 722 | 0.080 |
Why?
|
Cell Membrane Permeability | 1 | 2009 | 589 | 0.080 |
Why?
|
Neoplasm Metastasis | 3 | 2013 | 4832 | 0.070 |
Why?
|
Eye Neoplasms | 1 | 2009 | 314 | 0.070 |
Why?
|
Tissue Engineering | 3 | 2006 | 1869 | 0.070 |
Why?
|
Collagen | 2 | 2013 | 2671 | 0.070 |
Why?
|
Aged, 80 and over | 5 | 2020 | 57650 | 0.070 |
Why?
|
Heart Injuries | 1 | 2007 | 210 | 0.070 |
Why?
|
Peroxidase | 1 | 2008 | 608 | 0.070 |
Why?
|
Molecular Imaging | 1 | 2012 | 827 | 0.060 |
Why?
|
Alkaline Phosphatase | 2 | 2005 | 864 | 0.060 |
Why?
|
United States | 4 | 2022 | 69573 | 0.060 |
Why?
|
Fibrin Tissue Adhesive | 1 | 2005 | 84 | 0.060 |
Why?
|
Mice | 11 | 2014 | 81002 | 0.060 |
Why?
|
Patient Selection | 1 | 2016 | 4211 | 0.060 |
Why?
|
Calcium Phosphates | 1 | 2005 | 169 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15036 | 0.060 |
Why?
|
Medicare | 1 | 2022 | 6497 | 0.060 |
Why?
|
Odds Ratio | 1 | 2016 | 9846 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5462 | 0.060 |
Why?
|
Male | 10 | 2020 | 349022 | 0.060 |
Why?
|
Sulfonamides | 1 | 2012 | 1934 | 0.050 |
Why?
|
Pyrroles | 1 | 2009 | 1142 | 0.050 |
Why?
|
Peritoneal Neoplasms | 1 | 2009 | 663 | 0.050 |
Why?
|
Female | 11 | 2020 | 378853 | 0.050 |
Why?
|
Cattle | 2 | 2006 | 3913 | 0.050 |
Why?
|
Mice, Inbred BALB C | 2 | 2009 | 6397 | 0.050 |
Why?
|
Cell Adhesion | 1 | 2009 | 3137 | 0.050 |
Why?
|
Carotid Artery, Common | 1 | 2023 | 183 | 0.050 |
Why?
|
Animals | 14 | 2014 | 168368 | 0.050 |
Why?
|
Pyrazoles | 1 | 2012 | 1963 | 0.050 |
Why?
|
Family | 1 | 2013 | 3141 | 0.050 |
Why?
|
Contrast Media | 1 | 2015 | 5293 | 0.050 |
Why?
|
Protamines | 1 | 2021 | 106 | 0.050 |
Why?
|
Clavicle | 1 | 2023 | 206 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2014 | 18003 | 0.050 |
Why?
|
Stress, Psychological | 2 | 2013 | 4212 | 0.050 |
Why?
|
Indoles | 1 | 2009 | 1832 | 0.050 |
Why?
|
Laparoscopy | 1 | 2012 | 2091 | 0.050 |
Why?
|
Mice, Inbred C57BL | 3 | 2014 | 21863 | 0.050 |
Why?
|
Ventricular Remodeling | 1 | 2008 | 1222 | 0.050 |
Why?
|
Electric Stimulation | 1 | 2005 | 1769 | 0.050 |
Why?
|
Body Mass Index | 1 | 2017 | 12655 | 0.040 |
Why?
|
Singapore | 1 | 2020 | 295 | 0.040 |
Why?
|
Angiogenesis Inhibitors | 1 | 2009 | 2037 | 0.040 |
Why?
|
Anxiety | 1 | 2013 | 4253 | 0.040 |
Why?
|
Monocytes | 1 | 2007 | 2583 | 0.040 |
Why?
|
Limb Salvage | 1 | 2020 | 433 | 0.040 |
Why?
|
Quality Improvement | 1 | 2012 | 3730 | 0.040 |
Why?
|
Myocardial Infarction | 2 | 2008 | 11668 | 0.040 |
Why?
|
Mice, Transgenic | 3 | 2013 | 9734 | 0.030 |
Why?
|
Rats | 3 | 2006 | 24270 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2021 | 0.030 |
Why?
|
Vascular Surgical Procedures | 1 | 2023 | 1471 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2009 | 14558 | 0.030 |
Why?
|
Middle Aged | 6 | 2020 | 212863 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2013 | 7626 | 0.030 |
Why?
|
Sarcoma, Experimental | 1 | 2013 | 128 | 0.030 |
Why?
|
Hospital Costs | 1 | 2020 | 982 | 0.030 |
Why?
|
Propensity Score | 1 | 2020 | 1749 | 0.030 |
Why?
|
Models, Cardiovascular | 1 | 2018 | 997 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2012 | 6726 | 0.030 |
Why?
|
HT29 Cells | 1 | 2012 | 200 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 2009 | 4815 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2009 | 5213 | 0.030 |
Why?
|
Melanoma | 1 | 2009 | 5446 | 0.020 |
Why?
|
Hemorrhage | 1 | 2022 | 3441 | 0.020 |
Why?
|
Mice, Nude | 2 | 2009 | 3692 | 0.020 |
Why?
|
Sound | 1 | 2012 | 259 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2005 | 4920 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2012 | 612 | 0.020 |
Why?
|
Fluorescent Dyes | 2 | 2009 | 1925 | 0.020 |
Why?
|
Acute Disease | 1 | 2020 | 7128 | 0.020 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2009 | 188 | 0.020 |
Why?
|
Dalteparin | 1 | 2008 | 42 | 0.020 |
Why?
|
Inpatients | 1 | 2020 | 2478 | 0.020 |
Why?
|
Heart Rupture, Post-Infarction | 1 | 2008 | 49 | 0.020 |
Why?
|
Genes, p53 | 1 | 2009 | 752 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2012 | 2030 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2009 | 759 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2009 | 740 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 545 | 0.020 |
Why?
|
Length of Stay | 1 | 2020 | 6295 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2009 | 13635 | 0.020 |
Why?
|
Myogenin | 1 | 2005 | 58 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2020 | 5305 | 0.020 |
Why?
|
Peptide Hydrolases | 1 | 2009 | 627 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2013 | 6310 | 0.020 |
Why?
|
Species Specificity | 1 | 2009 | 2480 | 0.020 |
Why?
|
Gadolinium DTPA | 1 | 2008 | 836 | 0.020 |
Why?
|
Educational Status | 1 | 2013 | 2514 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2012 | 9387 | 0.020 |
Why?
|
Osseointegration | 1 | 2006 | 275 | 0.020 |
Why?
|
Receptors, Cholinergic | 1 | 2005 | 238 | 0.020 |
Why?
|
Random Allocation | 1 | 2009 | 2417 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2012 | 1405 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2012 | 3562 | 0.020 |
Why?
|
Myoblasts | 1 | 2005 | 237 | 0.020 |
Why?
|
Cell Transplantation | 1 | 2006 | 478 | 0.020 |
Why?
|
Registries | 1 | 2020 | 8039 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3922 | 0.010 |
Why?
|
Fibrin | 1 | 2005 | 506 | 0.010 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 1129 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2005 | 2049 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2727 | 0.010 |
Why?
|
Injections | 1 | 2005 | 837 | 0.010 |
Why?
|
Genome | 1 | 2009 | 1794 | 0.010 |
Why?
|
Cell Movement | 1 | 2013 | 5221 | 0.010 |
Why?
|
DNA Primers | 1 | 2005 | 2893 | 0.010 |
Why?
|
Magnetic Resonance Angiography | 1 | 2008 | 1441 | 0.010 |
Why?
|
Education, Medical | 1 | 2012 | 1712 | 0.010 |
Why?
|
Soft Tissue Neoplasms | 1 | 2009 | 1359 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2012 | 2275 | 0.010 |
Why?
|
Kinetics | 1 | 2007 | 6475 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2005 | 19220 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2013 | 11985 | 0.010 |
Why?
|
Down-Regulation | 1 | 2005 | 2999 | 0.010 |
Why?
|
Biocompatible Materials | 1 | 2006 | 1730 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2020 | 15194 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2009 | 8605 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2007 | 5959 | 0.010 |
Why?
|
RNA | 1 | 2005 | 2723 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2008 | 3620 | 0.010 |
Why?
|
Genotype | 1 | 2009 | 12951 | 0.010 |
Why?
|
Stroke Volume | 1 | 2008 | 4941 | 0.010 |
Why?
|
Genomics | 1 | 2009 | 5652 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2009 | 16646 | 0.010 |
Why?
|
Models, Statistical | 1 | 2006 | 5113 | 0.010 |
Why?
|
Algorithms | 1 | 2009 | 13872 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 2005 | 12049 | 0.000 |
Why?
|
Adult | 2 | 2013 | 213394 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 35326 | 0.000 |
Why?
|
Concepts
(230)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(38)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_